PRESS RELEASE

Effective date: 24 JUL 2015

Larix A/S takes over the projects and employees of Norma A/S

Today, 24th Jul 2015, Larix A/S signed a transfer agreement with Norma A/S (including its subsidiaries) in a takeover of Norma’s employees and ongoing projects. The transfer is effective as of 1st July, 2015.

Larix is a full service Nordic CRO offering assistance in all aspects of clinical studies to pharmaceutical, biotechnology, and medical device companies. Larix has been on the market for more than 14 years and our staff has a broad experience operating in all aspects of clinical and medical device studies and different therapeutic areas for both smaller and larger companies. Larix headquarters are located in Ballerup, with one Swedish affiliate located in Stockholm.

Larix takes over operations in Denmark, , and and with this transfer the total number of employees reaches 72.

“With this agreement we will add 15 new employees and two new countries – Finland and Norway - to Larix current organization. This is a big step forward in becoming a fully Nordic CRO and I am sure the next period will be both challenging and exiting for all of us.” says Klaus Juel Olsen, CEO and founder of Larix A/S

The transfer includes the important know-how, personnel employed by the contract research organization Norma and its existing projects. The addition will further increase Larix’ experience and competence in clinical trial services and also give a good Nordic distribution of its operations.

“Larix Sweden started in February 2015 and this transfer of additional employees and projects, both in Stockholm and Lund, is a good timing for us. It will give us a good push to become more established on the Swedish market, with more local services and employees to offer to our clients. ” says Eva Lundqvist, Country Manager Larix Sweden AB

More information about Larix Larix provide professional assistance within: • Statistics and Programming • Data Management • System Validation • Pharmacovigilance • Clinical Operations • Science and Medical Writing • Regulatory • Quality Assurance, System and Vendor auditing • Data Monitoring Committees Page 1 of 2 PRESS RELEASE

Effective date: 24 JUL 2015

We offer both outsourcing solutions of professionals for shorter or longer periods and full service solutions – where we take care of the entire clinical study - from planning, design, protocol writing and feasibility, through start-up and initiation, conduct, close-out and final reporting.

Larix has professional and flexible staff that focuses on: Communication – Proactivity – Quality on Time Our mission is to deliver high quality within agreed budget and timeline.

Contact details Larix: Larix A/S Tempovej 44 2750 Ballerup Denmark Tel: +45 70 27 22 21

Larix Sweden AB Karolinska Institutet Science Park Fogdevreten 2 A 171 65 Solna, Sweden Tel: +46 7 2050 3188.

Further contact details: http://www.larixcro.com/management_team_

The terms and conditions of the transfer are not disclosed.

For further information please contact: Klaus Juel Olsen, CEO Larix A/S Tempovej 44 2750 Ballerup Telephone number:+45 70 27 22 21 Fax number: +45 70 27 22 41 Mobile number: +45 61 61 80 11 Mail address: [email protected] Web address: www.larix.dk

Page 2 of 2